About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
University of Miami's 2nd Biennial Miami Leukemia Symposium
AML Biology and Treatment
MDS Biology and Treatment
ALL Biology and Treatment
CLL Therapy in 2019
CML and MPNs: Final Frontiers and New Breakthroughs
Myeloid Biology and Novel Therapies
Event
CLL Therapy in 2019
13:16
University of Miami's 2nd Biennial Miami Leukemia Symposium
Advances in the CLL Frontline Therapy: BTK Inhibitors vs. Chemoimmunotherapy, Venetoclax vs. Chemoimmunotherapy
FEATURING
Jennifer Woyach
154 views
May 14, 2020
1
07:09
University of Miami's 2nd Biennial Miami Leukemia Symposium
The Big Question in CLL Frontline Therapy: How to Choose Between Ibrutinib, Acalabrutinib & Venetoclax?
FEATURING
Jennifer Woyach
282 views
May 14, 2020
24:51
University of Miami's 2nd Biennial Miami Leukemia Symposium
2020 Update on Combination Therapies in R/R CLL: Venetoclax +R, Venetoclax + BTKi, Venetoclax + PI3Ki & BTKi + PI3Ki
FEATURING
Matthew Davids
56 views
May 14, 2020
